eliglustat and its Impurities
Eliglustat is a glucosylceramide synthase inhibitor indicated for the long-term treatment of type 1 Gaucher disease. Eliglustat, marketed by Genzyme as CERDELGA.. Reference standards of Eliglustat API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

![(1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2- PA 05 92510](https://www.pharmaffiliates.com/pimages/PA0592510.jpg)
(1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-((2-((2-hydroxy-1-phenylethyl)amino)ethyl)amino)-3-(pyrrolidin-1-yl)propan-1-ol
(1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-((2-((2-hydroxy-1-phenylethyl)amino)ethyl)amino)-3-(pyrrolidin-1-yl)propan-1-ol
Catalogue No.:PA 05 92510
CAS :
NA
Molecular Formula : C25H35N3O4
Molecular Weight : 441.57


N-[(1R,2S)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-octanamide
N-[(1R,2S)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-octanamide
Catalogue No.:PA 05 92540
CAS :
1092472-66-6
Molecular Formula : C23H36N2O4
Molecular Weight : 404.55

![N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 92550](https://www.pharmaffiliates.com/pimages/PA0592550.jpg)
N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)octanamide
N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)octanamide
Catalogue No.:PA 05 92550
CAS :
1092472-65-5
Molecular Formula : C23H36N2O4
Molecular Weight : 404.55

![(2S,3R)-2-Amino-3-(2,3-dihydrobenzo[b][1,4]dioxin- PA 05 0921001](https://www.pharmaffiliates.com/pimages/PA050921001.jpg)
(2S,3R)-2-Amino-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-hydroxy-1-(pyrrolidin-1-yl)propan-1-one
(2S,3R)-2-Amino-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-hydroxy-1-(pyrrolidin-1-yl)propan-1-one
Catalogue No.:PA 05 0921001
CAS :
NA
Molecular Formula : C15H20N2O4
Molecular Weight : 292.34

![(1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2- PA 05 0921003](https://www.pharmaffiliates.com/pimages/PA050921003.jpg)
(1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-(((S)-2-hydroxy-1-phenylethyl)amino)propane-1,3-diol
(1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-(((S)-2-hydroxy-1-phenylethyl)amino)propane-1,3-diol
Catalogue No.:PA 05 0921003
CAS :
NA
Molecular Formula : C19H23NO5
Molecular Weight : 345.4

![N-((1S,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 0921004](https://www.pharmaffiliates.com/pimages/PA050921004.jpg)
N-((1S,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)hexanamide
N-((1S,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)hexanamide
Catalogue No.:PA 05 0921004
CAS :
NA
Molecular Formula : C21H32N2O4
Molecular Weight : 376.5

![N-((1S,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 0921005](https://www.pharmaffiliates.com/pimages/PA050921005.jpg)
N-((1S,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)heptanamide
N-((1S,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)heptanamide
Catalogue No.:PA 05 0921005
CAS :
NA
Molecular Formula : C22H34N2O4
Molecular Weight : 390.52

![N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 0921006](https://www.pharmaffiliates.com/pimages/PA050921006.jpg)
N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-oxo-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide
N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-oxo-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide
Catalogue No.:PA 05 0921006
CAS :
NA
Molecular Formula : C24H36N2O5
Molecular Weight : 432.56

![1-((2R,3R)-3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 0921007](https://www.pharmaffiliates.com/pimages/PA050921007.jpg)
1-((2R,3R)-3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-hydroxy-2-nonanamidopropyl)pyrrolidine 1-Oxide
1-((2R,3R)-3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-hydroxy-2-nonanamidopropyl)pyrrolidine 1-Oxide
Catalogue No.:PA 05 0921007
CAS :
NA
Molecular Formula : C24H38N2O5
Molecular Weight : 434.58

![N-((2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1- PA 05 0921008](https://www.pharmaffiliates.com/pimages/PA050921008.jpg)
N-((2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide
N-((2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide
Catalogue No.:PA 05 0921008
CAS :
NA
Molecular Formula : C24H38N2O4
Molecular Weight : 418.58

![N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 0921009](https://www.pharmaffiliates.com/pimages/PA050921009.jpg)
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide
Catalogue No.:PA 05 0921009
CAS :
NA
Molecular Formula : C24H28N2O6
Molecular Weight : 440.5

![(1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2- PA 05 0921010](https://www.pharmaffiliates.com/pimages/PA050921010.jpg)
(1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-nonanamido-3-(pyrrolidin-1-yl)propyl Octanoate
(1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-nonanamido-3-(pyrrolidin-1-yl)propyl Octanoate
Catalogue No.:PA 05 0921010
CAS :
NA
Molecular Formula : C32H52N2O5
Molecular Weight : 544.78

![N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 0921015](https://www.pharmaffiliates.com/pimages/PA050921015.jpg)
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-7-hydroxyoctanamide
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-7-hydroxyoctanamide
Catalogue No.:PA 05 0921015
CAS :
NA
Molecular Formula : C23H36N2O5
Molecular Weight : 420.55

![N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 0921016](https://www.pharmaffiliates.com/pimages/PA050921016.jpg)
N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-oxo-3-(pyrrolidin-1-yl)propan-2-yl)octanamide
N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-oxo-3-(pyrrolidin-1-yl)propan-2-yl)octanamide
Catalogue No.:PA 05 0921016
CAS :
2313482-21-0
Molecular Formula : C23H34N2O5
Molecular Weight : 418.53

![N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 0921019](https://www.pharmaffiliates.com/pimages/PA050921019.jpg)
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(nitroso(4-oxobutyl)amino)propan-2-yl)octanamide
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(nitroso(4-oxobutyl)amino)propan-2-yl)octanamide
Catalogue No.:PA 05 0921019
CAS :
NA
Molecular Formula : C23H35N3O6
Molecular Weight : 449.55

![N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 0921020](https://www.pharmaffiliates.com/pimages/PA050921020.jpg)
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-N-(2-((2-hydroxy-1-phenylethyl)amino)ethyl)nitrous amide
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-N-(2-((2-hydroxy-1-phenylethyl)amino)ethyl)nitrous amide
Catalogue No.:PA 05 0921020
CAS :
NA
Molecular Formula : C25H34N4O5
Molecular Weight : 470.57

![N-(2-(((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6 PA 05 0921021](https://www.pharmaffiliates.com/pimages/PA050921021.jpg)
N-(2-(((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)amino)ethyl)-N-(2-hydroxy-1-phenylethyl)nitrous amide
N-(2-(((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)amino)ethyl)-N-(2-hydroxy-1-phenylethyl)nitrous amide
Catalogue No.:PA 05 0921021
CAS :
NA
Molecular Formula : C25H34N4O5
Molecular Weight : 470.57

![N-(2-(((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6 PA 05 0921022](https://www.pharmaffiliates.com/pimages/PA050921022.jpg)
N-(2-(((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)(nitroso)amino)ethyl)-N-(2-hydroxy-1-phenylethyl)nitrous amide
N-(2-(((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)(nitroso)amino)ethyl)-N-(2-hydroxy-1-phenylethyl)nitrous amide
Catalogue No.:PA 05 0921022
CAS :
NA
Molecular Formula : C25H33N5O6
Molecular Weight : 499.57

![N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 0921024](https://www.pharmaffiliates.com/pimages/PA050921024.jpg)
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)decanamide
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)decanamide
Catalogue No.:PA 05 0921024
CAS :
491833-31-9
Molecular Formula : C25H40N2O4
Molecular Weight : 432.61

![N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl) PA 05 0921027](https://www.pharmaffiliates.com/pimages/PA050921027.jpg)
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide
Catalogue No.:PA 05 0921027
CAS :
491833-30-8
Molecular Formula : C24H38N2O4
Molecular Weight : 418.58